[go: up one dir, main page]

CL2018000504A1 - Compuestos carbociclicos novedosos como moduladores gamma ror. - Google Patents

Compuestos carbociclicos novedosos como moduladores gamma ror.

Info

Publication number
CL2018000504A1
CL2018000504A1 CL2018000504A CL2018000504A CL2018000504A1 CL 2018000504 A1 CL2018000504 A1 CL 2018000504A1 CL 2018000504 A CL2018000504 A CL 2018000504A CL 2018000504 A CL2018000504 A CL 2018000504A CL 2018000504 A1 CL2018000504 A1 CL 2018000504A1
Authority
CL
Chile
Prior art keywords
gamma
roryt
carbocyclic compounds
novel carbocyclic
compounds
Prior art date
Application number
CL2018000504A
Other languages
English (en)
Inventor
Sanjib Das
Laxmikant At­Maram Gharat
Rajendra Laxman Harde
Dnyaneshwar Eknath Shelke
Shailesh Ramesh Pardeshi
Abraham Thomas
Neelima Khairatkar-Joshi
Daisy Manish Shah
Malini Bajpai
Original Assignee
Glenmark Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Sa filed Critical Glenmark Pharmaceuticals Sa
Publication of CL2018000504A1 publication Critical patent/CL2018000504A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

<p>La presente descripción está dirigida a compuestos carbocíclicos novedosos de fórmula (I) y sales farmacéuticamente aceptables de los mismos, en donde R1, R2, R3, R4, R5, R6, Rª, Rh, n, m y p son como se definen aquí, activos como moduladores relacionados con el retinoide receptor huérfano gamma t (RORyt). Estos compuestos previenen, inhiben o suprimen la acción de RORyt y, por lo tanto, son útiles en el tratamiento de enfermedades, trastornos, síndromes o afecciones mediadas por RORyt, como, por ejemplo, dolor, inflamación, EPOC, asma, artritis reumatoide, colitis, esclerosis múltiple, psoriasis, enfermedades neurodegenerativas y cáncer.</p>
CL2018000504A 2015-08-28 2018-02-26 Compuestos carbociclicos novedosos como moduladores gamma ror. CL2018000504A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3299MU2015 2015-08-28

Publications (1)

Publication Number Publication Date
CL2018000504A1 true CL2018000504A1 (es) 2018-07-06

Family

ID=58186928

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018000504A CL2018000504A1 (es) 2015-08-28 2018-02-26 Compuestos carbociclicos novedosos como moduladores gamma ror.

Country Status (16)

Country Link
US (2) US10189775B2 (es)
EP (1) EP3341357A4 (es)
JP (1) JP2018526372A (es)
KR (1) KR20180044384A (es)
CN (1) CN108026039A (es)
AU (1) AU2016314547A1 (es)
CA (1) CA2996017A1 (es)
CL (1) CL2018000504A1 (es)
EA (1) EA201890330A1 (es)
HK (1) HK1257756A1 (es)
IL (1) IL257525A (es)
MX (1) MX2018002478A (es)
PE (1) PE20181178A1 (es)
PH (1) PH12018500411A1 (es)
WO (1) WO2017037595A1 (es)
ZA (1) ZA201801268B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018042342A1 (en) * 2016-08-30 2018-03-08 Glenmark Pharmaceuticals S.A. 1,2,3-benzotriazole derivatives as ror gamma t modulators
WO2018193297A1 (en) 2017-04-21 2018-10-25 Cadila Healthcare Limited Novel compounds as ror-gamma modulators
CN113880774B (zh) * 2020-07-02 2023-12-08 沈阳中化农药化工研发有限公司 一种苯基异恶唑啉类化合物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
JP2002179651A (ja) * 1998-06-19 2002-06-26 Wakamoto Pharmaceut Co Ltd ベンズアニリド誘導体及び医薬組成物
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US8501982B2 (en) * 2010-06-09 2013-08-06 Receptos, Inc. GLP-1 receptor stabilizers and modulators
WO2012027965A1 (en) 2010-09-01 2012-03-08 Glaxo Group Limited Novel compounds
WO2012028100A1 (en) 2010-09-01 2012-03-08 Glaxo Group Limited Novel compounds
US8772562B2 (en) 2010-11-10 2014-07-08 Exxonmobil Research And Engineering Company Process for making basestocks from renewable feedstocks
WO2012100734A1 (en) 2011-01-24 2012-08-02 Glaxo Group Limited Compounds useful as retinoid-related orphan receptor gamma modulators
WO2012100732A1 (en) 2011-01-24 2012-08-02 Glaxo Group Limited Retinoid-related orphan receptor gamma modulators, composition containing them and uses thereof
EP2511263A1 (en) 2011-04-14 2012-10-17 Phenex Pharmaceuticals AG Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
WO2013171729A2 (en) * 2013-01-08 2013-11-21 Glenmark Pharmaceuticals S.A. Aryl and heteroaryl amide compounds as rorgamat modulator
WO2015008234A1 (en) 2013-07-17 2015-01-22 Glenmark Pharmaceuticals S.A. Bicyclic heterocyclic compounds as ror gamma modulators

Also Published As

Publication number Publication date
EP3341357A4 (en) 2019-03-27
CN108026039A (zh) 2018-05-11
PH12018500411A1 (en) 2018-08-29
US10189775B2 (en) 2019-01-29
PE20181178A1 (es) 2018-07-20
KR20180044384A (ko) 2018-05-02
MX2018002478A (es) 2018-06-15
JP2018526372A (ja) 2018-09-13
AU2016314547A1 (en) 2018-03-22
US10336688B2 (en) 2019-07-02
ZA201801268B (en) 2019-05-29
IL257525A (en) 2018-04-30
HK1257756A1 (zh) 2019-10-25
CA2996017A1 (en) 2017-03-09
EA201890330A1 (ru) 2018-07-31
US20190144375A1 (en) 2019-05-16
EP3341357A1 (en) 2018-07-04
WO2017037595A1 (en) 2017-03-09
US20180237382A1 (en) 2018-08-23

Similar Documents

Publication Publication Date Title
MX2020001361A (es) Compuestos nuevos como moduladores de ror gamma.
PH12016502045A1 (en) Aryl and heteroaryl ether compounds as ror gamma modulators
EA201691002A1 (ru) Бициклические гетероарильные аналоги индола, подходящие в качестве модуляторов ror гамма
CU24487B1 (es) Compuestos de tetrahidroquinolinona sustituidos como moduladores de gamma ror
PE20151144A1 (es) Moduladores de la orphan receptor gamma retinoides relacionados (ror - gamma) para uso en el tratamiento de las enfermedades autoinmunes e inflamatorias
ECSP18094790A (es) Piridinas sustituidas con heteroarilo y métodos de uso referencia cruzada a solicitudes relacionadas
WO2013171729A3 (en) Aryl and heteroaryl amide compounds as ror gamma t modulator
CL2024001474A1 (es) Compuestos derivados de heterociclos sustituidos, activadores akt3; composición farmacéutica; y uso
PE20180119A1 (es) Sulfonas triciclicas como moduladores del receptor huerfano relacionado con retinoide gamma (rorgamma)
CU24516B1 (es) Derivados aromáticos de sulfonamida útiles como medicamentos contra enfermedades asociadas con dolor
DOP2016000125A (es) MODULADORES DE ROR GAMMA (RORy)
ECSP20024651A (es) Derivados de imidazol condensados sustituidos por grupos de hidroxilo terciario como inhibidores de gamma pi3k-y
CU20200067A7 (es) Derivados de imidazolidin-2-ona sustituidos como inhibidores de prmt5
UY36709A (es) Moduladores de ror gamma (ror¿)
UY36377A (es) Compuestos tiazoles sustituidos como moduladores del receptor nuclear ror t y composiciones farmacéuticas que los contienen
MX2018008454A (es) Derivado de amina ciclica y uso medico del mismo.
CL2018000504A1 (es) Compuestos carbociclicos novedosos como moduladores gamma ror.
MX2019003310A (es) Inhibidores de dopamina-b-hidroxilasa.
MX2019004973A (es) Moduladores de ror gamma.
MX2019011265A (es) Derivados del acido acetico azaindol y su uso como moduladores de receptor de prostaglandina d2.
MX2019005090A (es) Derivados de piridazina como moduladores de receptor gamma huerfano relacionado a acido retinoico (rorc).
UY36398A (es) NUEVOS MODULADORES DEL RECEPTOR GAMMA HUERFANO RELACIONADO CON RETINOIDE (RORy)
AR098679A1 (es) COMPUESTOS DE HETEROARILO BICÍCLICO COMO MODULADORES DE RORg